Key Record Dates
ClinicalTrials.gov Identifier: | NCT03793166 |
---|---|
Brief Title: | Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study |
First Submitted : | January 3, 2019 |
First Submitted that Met QC Criteria : | January 3, 2019 |
First Posted : | January 4, 2019 |
Last Update Submitted that Met QC Criteria : | June 1, 2023 |
Last Update Posted : | June 2, 2023 (Estimate) |